Patient-reported utilities in advanced or metastatic melanoma, including analysis of utilities by time to death

Hatswell, A.J., Pennington, B., Pericleous, L. et al. (3 more authors) (2014) Patient-reported utilities in advanced or metastatic melanoma, including analysis of utilities by time to death. Health and Quality of Life Outcomes, 12. 140. ISSN 1477-7525

Abstract

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: © 2014 Hatswell et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Keywords: Preference-based utilities; EORTC-8D; SF-6D; Melanoma; Ipilimumab; MDX010-20
Dates:
  • Published (online): 10 September 2014
  • Accepted: 28 August 2014
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > School of Health and Related Research (Sheffield) > Sheffield Centre for Health and Related Research
Depositing User: Symplectic Sheffield
Date Deposited: 09 Dec 2016 12:15
Last Modified: 10 Mar 2017 12:07
Published Version: https://doi.org/10.1186/s12955-014-0140-1
Status: Published
Publisher: BioMed Central
Refereed: Yes
Identification Number: https://doi.org/10.1186/s12955-014-0140-1
Related URLs:

Share / Export

Statistics